Key Highlights
- Texas Instruments exceeded Q1 2026 expectations with earnings per share of $1.68 compared to analyst projections of $1.36
- Quarterly revenue reached $4.83 billion, surpassing the anticipated $4.52 billion
- Industrial business segment expanded over 20% sequentially; Data Center operations increased more than 25%
- Barclays elevated TXN rating to Equalweight, increasing price objective from $175 to $250
- Several Wall Street firms boosted price projections, with KeyBanc reaching $325 and Rosenblatt hitting $330
Texas Instruments delivered impressive first-quarter 2026 performance, exceeding Wall Street projections across key metrics. The company reported earnings per share of $1.68, significantly outpacing the consensus estimate of $1.36. Quarterly revenue totaled $4.83 billion compared to analyst expectations of $4.52 billion.
Shares rallied approximately 16% following the announcement, climbing from roughly $233 to around $274 per share.
Texas Instruments Incorporated, TXN
The quarterly outperformance stemmed primarily from robust momentum in two critical business segments: Industrial and Data Center. The Industrial division posted sequential growth exceeding 20% in March. Meanwhile, the Data Center segment expanded by more than 25% during the identical timeframe.
Management’s Q2 outlook came in modestly above typical seasonal patterns, suggesting sustained momentum in these two divisions. However, UBS noted that Automotive sector demand continued to show volatility.
Wall Street Reaction and Target Adjustments
Barclays delivered the most significant revision, elevating TXN from Underweight to Equalweight while raising its price objective from $175 to $250. The brokerage attributed the adjustment to strengthening fundamentals in Industrial and Data Center markets.
Barclays projects Data Center revenue to surge over 90% throughout calendar year 2026. The firm also anticipates Industrial segment performance will exceed seasonal patterns again in June.
The investment bank now forecasts $10 per share in free cash flow generation for TXN during calendar 2027. This projection stands above the prevailing consensus forecast of approximately $8.55.
UBS maintained its Buy recommendation while elevating its price objective from $260 to $295. The firm indicated results aligned with heightened market expectations, while forward guidance provided a modest upside surprise.
Cantor Fitzgerald increased its target from $250 to $280 while maintaining a Neutral stance. The firm applied an elevated 28x valuation multiple compared to its prior 25x, acknowledging improving conditions across analog semiconductor markets.
Additional Street Commentary
KeyBanc established the most optimistic projection, raising its target to $325. BofA Securities upgraded TXN to Buy with a $320 objective, highlighting robust activity in aerospace and defense applications within the industrial portfolio.
Rosenblatt elevated its price target to $330. Baird moved its forecast to $300. Wolfe Research, observing that Q1 revenue climbed 9% sequentially, established a $315 target.
TXN currently commands approximately 26 times free cash flow, trading above its historical mid-teens valuation range. The forward P/E ratio stands at 43.15.
Barclays cautioned that the company faces execution challenges regarding Street estimates for the latter half of the year. Cantor Fitzgerald also highlighted uncertainties surrounding memory supply constraints and geopolitical factors as reasons for maintaining selectivity across the broader semiconductor sector.
Shares were changing hands near $274, approaching the previous 52-week peak of $238.80 established before the earnings-driven surge.
